Anavex Life Sciences Corp. (NASDAQ:AVXL - Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $8.30, but opened at $8.60. Anavex Life Sciences shares last traded at $8.48, with a volume of 193,857 shares traded.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on AVXL shares. HC Wainwright reaffirmed a "buy" rating and issued a $40.00 target price on shares of Anavex Life Sciences in a research note on Wednesday, November 27th. D. Boral Capital restated a "buy" rating and issued a $46.00 price objective on shares of Anavex Life Sciences in a research report on Monday, November 25th.
Check Out Our Latest Stock Report on AVXL
Anavex Life Sciences Price Performance
The firm has a market cap of $717.41 million, a price-to-earnings ratio of -16.92 and a beta of 0.73. The business's 50-day moving average price is $7.33 and its two-hundred day moving average price is $5.99.
Institutional Trading of Anavex Life Sciences
Hedge funds have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company lifted its holdings in shares of Anavex Life Sciences by 8.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 30,510 shares of the biotechnology company's stock worth $129,000 after acquiring an additional 2,401 shares during the period. Franklin Resources Inc. increased its position in Anavex Life Sciences by 6.7% during the third quarter. Franklin Resources Inc. now owns 58,557 shares of the biotechnology company's stock worth $317,000 after purchasing an additional 3,674 shares during the last quarter. Private Advisor Group LLC raised its stake in Anavex Life Sciences by 10.3% during the third quarter. Private Advisor Group LLC now owns 47,413 shares of the biotechnology company's stock worth $269,000 after purchasing an additional 4,442 shares during the period. China Universal Asset Management Co. Ltd. boosted its holdings in shares of Anavex Life Sciences by 64.0% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 16,309 shares of the biotechnology company's stock valued at $93,000 after purchasing an additional 6,366 shares during the last quarter. Finally, BNP Paribas Financial Markets grew its stake in shares of Anavex Life Sciences by 97.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 15,074 shares of the biotechnology company's stock valued at $86,000 after buying an additional 7,421 shares during the period. 31.55% of the stock is owned by institutional investors and hedge funds.
Anavex Life Sciences Company Profile
(
Get Free Report)
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome.
Read More
Before you consider Anavex Life Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anavex Life Sciences wasn't on the list.
While Anavex Life Sciences currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
